These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 15129876
1. PSG consensus statement on management of hepatitis C virus infection--2003. Hamid S, Umar M, Alam A, Siddiqui A, Qureshi H, Butt J, Pakistan Society of Gastroenterology. J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876 [No Abstract] [Full Text] [Related]
5. Consensus guidelines for the management of hepatitis C infection. Consensus Guidelines Committee for the Management of Hepatitis C Infection. Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186 [Abstract] [Full Text] [Related]
10. [Drug therapy of hepatitis B and C]. Färkkilä M. Duodecim; 2003 Jul; 119(6):519-29. PubMed ID: 12708339 [No Abstract] [Full Text] [Related]
11. [Effectiveness of long-acting interferon (peginterferon)]. Kondo Y, Tateishi R, Yoshida H, Omata M. Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):515-8. PubMed ID: 15359853 [No Abstract] [Full Text] [Related]
12. Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2b. Sharara AI, Aoun E, Koussa S, Inati A, Taher A. J Gastroenterol Hepatol; 2006 Jul; 21(7):1221. PubMed ID: 16824084 [No Abstract] [Full Text] [Related]
13. Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia. Bruchfeld A, Lindahl K, Stahle L, Schvarcz R. J Hepatol; 2006 Feb; 44(2):432-3; author reply 433. PubMed ID: 16338023 [No Abstract] [Full Text] [Related]
14. Treatment of acute hepatitis C-how to explain the differences? Wedemeyer H, Cornberg M, Wiegand J, Jäckel E, Manns MP. Gastroenterology; 2006 Aug; 131(2):682-3; author reply 683-4. PubMed ID: 16890627 [No Abstract] [Full Text] [Related]
15. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy. Chen TM, Huang PT, Tsai MH, Lin LF, Liu CC, Ho KS, Siauw CP, Chao PL, Tung JN. J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854 [Abstract] [Full Text] [Related]
16. Pegylated interferon alpha-2b in patients with acute hepatitis C. Mukhopadhyay A. Natl Med J India; 2006 May; 19(4):201-2. PubMed ID: 17100108 [No Abstract] [Full Text] [Related]
17. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection. Asian Pacific Association for the Study of the Liver (APASL) Hepatitis C Working PartyCentenary Research Institute, AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, University of Sydney, NSW 2006, Australia. g.mccaughan@centenary.usyd.edu.au, McCaughan GW, Omata M, Amarapurkar D, Bowden S, Chow WC, Chutaputti A, Dore G, Gane E, Guan R, Hamid SS, Hardikar W, Hui CK, Jafri W, Jia JD, Lai MY, Wei L, Leung N, Piratvisuth T, Sarin S, Sollano J, Tateishi R. J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847 [No Abstract] [Full Text] [Related]
18. Current status of hepatitis C virus infection in Korea. Suh DJ, Jeong SH. Intervirology; 2006 May; 49(1-2):70-5. PubMed ID: 16166792 [Abstract] [Full Text] [Related]
19. [Postoperative interferon therapy after resection of hepatitis C virus-related hepatocellular carcinoma]. Katagiri S, Tokushige K, Yamamoto M. Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):795-801. PubMed ID: 18525184 [No Abstract] [Full Text] [Related]
20. [Hepatitis C virus genotype 4: epidemiology and treatment]. Castera L, Morice Y, Grando V, Bon C, Dény P, Roulot D. Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]